Company Description
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.
The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more.
In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021.
LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1994 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 352 |
| CEO | Justin Schreiber |
Contact Details
Address: 236 Fifth Avenue, Suite 400 New York, New York 10001 United States | |
| Phone | 866 351 5907 |
| Website | lifemd.com |
Stock Details
| Ticker Symbol | LFMD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 948320 |
| CUSIP Number | 53216B104 |
| ISIN Number | US53216B1044 |
| Employer ID | 76-0238453 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Justin Schreiber | Chairman and Chief Executive Officer |
| Shayna Webb Dray | Chief Operating Officer |
| Stefan Galluppi | Chief Innovation Officer |
| Atul Kavthekar | Chief Financial Officer |
| Maria E. Stan CPA | Chief Accounting Officer and Controller |
| Dennis Wijnker | Chief Technology Officer |
| Eric H. Yecies | Chief Legal Officer, General Counsel and Corporate Secretary |
| Shane Biffar | Chief Compliance Officer and Deputy General Counsel |
| Chris Pisano | Chief Marketing Officer |
| Nicholas P. Alvarez | Chief Acquisition Officer and Head of Customer Acquisition |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 6, 2026 | 10-Q | Quarterly Report |
| May 6, 2026 | 8-K | Current Report |
| Apr 30, 2026 | ARS | Filing |
| Apr 30, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 30, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 30, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 1, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 23, 2026 | 144 | Filing |
| Mar 18, 2026 | 8-K | Current Report |
| Mar 10, 2026 | 10-K | Annual Report |